Interstitial granulomatous dermatitis occurring in a patient with SAPHO syndrome one month after starting leflunomide, and subsequently disappearing with ustekinumab

European Journal of Dermatology

Volumn 26, Issue 6, 2016, Pages 614-615

  Cornillier, Hélène ^a   Kervarrec, Thibault ^a   Tabareaudelalande, Flore ^a   Mammou, Saloua ^a   Jonville Bera, Annie Pierre ^a   Machet, Laurent ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; COLESTYRAMINE; ETANERCEPT; LEFLUNOMIDE; METHOTREXATE; USTEKINUMAB; DERMATOLOGICAL AGENT; IMMUNOSUPPRESSIVE AGENT; ISOXAZOLE DERIVATIVE;

ADULT; ARTHRALGIA; ARTHRITIS; CASE REPORT; CELL INFILTRATION; DERMATITIS; DRUG CLEARANCE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; LETTER; PUSTULOSIS PALMOPLANTARIS; SAPHO SYNDROME; SKIN BIOPSY; ACQUIRED HYPEROSTOSIS SYNDROME; CHEMICALLY INDUCED; DRUG ERUPTIONS; GRANULOMA;

ACQUIRED HYPEROSTOSIS SYNDROME; ADULT; DERMATITIS; DERMATOLOGIC AGENTS; DRUG ERUPTIONS; FEMALE; GRANULOMA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; USTEKINUMAB;

EID: 85007495805     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2016.2854     Document Type: Letter

References (9)

1. Peroni A, Colato C, Schena D, Gisondi P, Girolomoni G. Interstitial granulomatous dermatitis: A distinct entity with characteristic histological and clinical pattern. Br J Dermatol 2012; 166: 775-83.
2. Georgesen C, McDonough P, Cruz P. Interstitial granulomatous dermatitis associated with gabapentin. Dermatitis 2014; 25: 374-5.
3. Laura A, Luca P, Luisa PA. Interstitial granulomatous drug reaction due to febuxostat. Indian J Dermatol Venereol Leprol 2014; 80: 182-4.
4. Martínez-Morán C, Nájera L, Ruiz-Casado AI, et al. Interstitial granulomatous drug reaction to sorafenib. Arch Dermatol 2011; 147: 1118-9.
5. Martín G, Cañueto J, Santos-Briz A, Alonso G, Unamuno PD, Cruz JJ. Interstitial granulomatous dermatitis with arthritis associated with trastuzumab. J Eur Acad Dermatol Venereol 2010; 24: 493-4.
6. Gharsallah I, Souissi A, Dhahri R, et al. Le syndrome SAPHO. Rev Med Int 2014; 35: 595-600.
7. Guerin M, Haettich B, Bara C, et al. Lupus attributable to anti-TNF therapy and revealed by interstitial granulomatous dermatitis. Rheumatol Int 2012; 32: 2937-40.
8. Firinu D, Murgia G, Lorrai MM, et al. Biological treatments for SAPHO syndrome: An update. Inflamm Allergy Drug Targets 2014; 13: 199-205.
9. Leloup P, Aubert H, Causse S, Le Goff B, Barbarot S. Ustekinumab therapy for severe interstitial granulomatous dermatitis with arthritis. JAMA Dermatol 2013; 149: 626.